Improvement of the Head and Neck Regions with Continuous Tralokinumab treatment for Up to 4 years in Adults with Moderate-to-Severe Atopic Dermatitis. (2024). SKIN The Journal of Cutaneous Medicine, 8(1), s316. https://doi.org/10.25251/skin.8.supp.316